Product Information

GRISEOFULVIN 125 MG/5 ML SUSP is a generic product labeled by Cosette Pharmaceuticals, Inc., priced at $0.4167 per ML under NDC 00713085004. Its NADAC has been published 196 times since Feb 22, 2023.

FDA first approved this application on Oct 8, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

GRISEOFULVIN 125 MG/5 ML SUSP

Griseofulvin
$0.4167per ML

Strength

125 mg/5mL

NDC

00713085004

Classification

Generic

Dosage Form

SUSPENSION

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

GRISEOFULVIN

Approval Type

Generic (ANDA)

FDA Application

ANDA065438

FDA Approved

10/8/2010

TE Code

AB

On Market Since

11/1/2022

Pharmacological Classes

Decreased Mitosis
Microtubule Inhibition
Tubulin Inhibiting Agent

Price Statistics

The NADAC for GRISEOFULVIN 125 MG/5 ML SUSP has been published 196 times since Feb 22, 2023, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$0.4167 per ML
All-time high$1.0444 (Oct 16, 2024)
All-time low$0.3348 (Apr 22, 2026)
52-week high$0.4167
52-week low$0.3348
Median price$0.4112
Average price$0.5068
Largest weekly change+65.1% (Feb 21, 2024)
Weeks tracked196
Tracking sinceFeb 22, 2023

Price History

1W

+1.2%

1M

+6.5%

3M

+5.5%

6M

+16.8%

1Y

+2.7%

3Y

+9.7%

5Y

N/A

All

+1.5%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 45% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

Save up to 45%

1 alternative • Same active ingredient

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of GRISEOFULVIN 125 MG/5 ML SUSP?

The current National Average Drug Acquisition Cost (NADAC) for GRISEOFULVIN 125 MG/5 ML SUSP, manufactured by Cosette Pharmaceuticals, Inc., is $0.4167 per ML (NDC 00713085004), effective Nov 18, 2026.

How has the price of GRISEOFULVIN 125 MG/5 ML SUSP changed over time?

Over the history we have for it, the NADAC for GRISEOFULVIN 125 MG/5 ML SUSP has held within roughly two percent of its current level. It has been tracked across 196 weekly CMS publications since Feb 22, 2023.

What are the highest and lowest recorded NADAC prices for GRISEOFULVIN 125 MG/5 ML SUSP?

Since Feb 22, 2023, the NADAC for GRISEOFULVIN 125 MG/5 ML SUSP has ranged from a low of $0.3348 (Apr 22, 2026) to a high of $1.0444 (Oct 16, 2024), with a median of $0.4112 per ML.

Are there cheaper alternatives to GRISEOFULVIN 125 MG/5 ML SUSP?

Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, GRISEOFULVIN 125 MG/5 ML SUSP, is $0.2287 per ML — about 45% below GRISEOFULVIN 125 MG/5 ML SUSP.

Who manufactures GRISEOFULVIN 125 MG/5 ML SUSP?

GRISEOFULVIN 125 MG/5 ML SUSP (NDC 00713085004) is labeled by Cosette Pharmaceuticals, Inc., and CMS classifies it as a generic product.